• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".

作者信息

Pastori Daniele, Farcomeni Alessio, Bucci Tommaso, Cangemi Roberto, Ciacci Paolo, Vicario Tommasa, Violi Francesco, Pignatelli Pasquale

机构信息

I Clinica Medica, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Umberto I Policlinico of Rome, Italy.

Department of Public Health and Infectious Diseases, Statistics Section, Sapienza University of Rome, Italy.

出版信息

Int J Cardiol. 2015 Jun 15;189:247-8. doi: 10.1016/j.ijcard.2015.04.125. Epub 2015 Apr 16.

DOI:10.1016/j.ijcard.2015.04.125
PMID:25897918
Abstract
摘要

相似文献

1
Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".对《地高辛还是使用地高辛的患者？随机试验对于鉴别地高辛与死亡率增加之间关联的主要危险因素至关重要》的回应
Int J Cardiol. 2015 Jun 15;189:247-8. doi: 10.1016/j.ijcard.2015.04.125. Epub 2015 Apr 16.
2
Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.是地高辛还是给患者开了地高辛？随机试验对于辨别地高辛与死亡率增加之间关联的主要风险因素至关重要。
Int J Cardiol. 2015 Apr 1;184:512-513. doi: 10.1016/j.ijcard.2015.03.029. Epub 2015 Mar 3.
3
Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中，地高辛治疗与全因死亡率和心血管死亡率增加相关。
Int J Cardiol. 2015 Feb 1;180:1-5. doi: 10.1016/j.ijcard.2014.11.112. Epub 2014 Nov 18.
4
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).地高辛在伴有不良心血管结局的心房颤动患者中的应用：利伐沙班每日一次口服直接 Xa 因子抑制剂与维生素 K 拮抗剂预防心房颤动卒中及栓塞的临床试验（ROCKET AF）的回顾性分析。
Lancet. 2015 Jun 13;385(9985):2363-70. doi: 10.1016/S0140-6736(14)61836-5. Epub 2015 Mar 6.
5
Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.地高辛对心力衰竭分层的心房颤动患者死亡率的影响：中东地区心房颤动事件海湾调查结果
J Cardiovasc Pharmacol Ther. 2016 May;21(3):273-9. doi: 10.1177/1074248415603505. Epub 2015 Sep 3.
6
Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.地高辛治疗心房颤动和心房扑动：随机临床试验的系统评价与荟萃分析和试验序贯分析。
PLoS One. 2018 Mar 8;13(3):e0193924. doi: 10.1371/journal.pone.0193924. eCollection 2018.
7
Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.在≥65 岁伴或不伴心力衰竭的心房颤动患者中，地高辛的使用与全因死亡率的关系。
Am J Cardiol. 2014 Aug 1;114(3):401-6. doi: 10.1016/j.amjcard.2014.05.013. Epub 2014 May 16.
8
Digoxin and mortality in atrial fibrillation: a prospective cohort study.地高辛与心房颤动患者死亡率：一项前瞻性队列研究。
Eur J Clin Pharmacol. 2007 Oct;63(10):959-71. doi: 10.1007/s00228-007-0346-9. Epub 2007 Aug 8.
9
Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.高血压合并心房颤动患者使用地高辛与死亡风险
J Hypertens. 2015 Jul;33(7):1480-6. doi: 10.1097/HJH.0000000000000559.
10
Digoxin mortality in heart failure and atrial fibrillation.
Eur Heart J. 2015 Aug 7;36(30):1944-5.